Haemonetics (HAE) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $76.49 -1.04%
Revenue Growth %: +2.3%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Revenue Growth %: +2.3%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $0.90, $0.01 better than the analyst estimate of $0.89. Revenue for the quarter came in at $343.29 million versus the consensus estimate of $329.47 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- Morgan Stanley continues to recommend exposure to the broadening theme
- Hormel Foods agrees to sell Brazil's Ceratti brand to Zanchetta
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
